Literature DB >> 6293153

Transmission of feline viral rhinotracheitis.

R M Gaskell, R C Povey.   

Abstract

The transmission of feline viral rhinotracheitis (FVR) virus was investigated. Virus could be successfully transmitted between shedding carrier cats and unrelated susceptible kittens, but only if there was intimate contact between them. Studies on the transmission of FVR virus from carrier queens to their kittens showed that although four of 10 queens shed virus in the post partum period, a total of only four kittens from three litters developed a contact infection. All four kittens remained asymptomatic. Two shed for one day only and did not become carriers (as evidenced by corticosteroid treatment) and two shed for 15 days and 25 days and were subsequently shown to have become carriers. None of the remaining kittens tested shed virus. There was no evidence of in utero transmission between FVR-recovered queens and kittens. Passive antibody titres in kittens born to FVR-recovered queens declined to less than 1 in 4 in individual animals by two to 10 weeks of age. Mean titres calculated from a linear regression equation reached less than 1 in 4 and less than 1 in 2 by six and nine weeks of age, respectively. Experiments using a multistage liquid impinger demonstrated that FVR virus was unlikely to be transmitted between cats by aerosol and this was confirmed by the ability of a sentinel cat to withstand virus shedding from carriers over a six month period, although housed in the same air space.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6293153     DOI: 10.1136/vr.111.16.359

Source DB:  PubMed          Journal:  Vet Rec        ISSN: 0042-4900            Impact factor:   2.695


  9 in total

1.  Homology between feline herpesvirus-1 and canine herpesvirus.

Authors:  P A Rota; R K Maes
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

2.  Comparison of polymerase chain reaction tests for diagnosis of feline herpesvirus, Chlamydophila felis, and Mycoplasma spp. infection in cats with ocular disease in Canada.

Authors:  Lynne S Sandmeyer; Cheryl L Waldner; Bianca S Bauer; Xin Wen; Dorothee Bienzle
Journal:  Can Vet J       Date:  2010-06       Impact factor: 1.008

Review 3.  The epidemiology of viral infections in dogs and cats.

Authors:  J S Reif
Journal:  Vet Clin North Am Small Anim Pract       Date:  1986-11       Impact factor: 2.093

4.  True versus false parasite interactions: a robust method to take risk factors into account and its application to feline viruses.

Authors:  Eléonore Hellard; Dominique Pontier; Frank Sauvage; Hervé Poulet; David Fouchet
Journal:  PLoS One       Date:  2012-01-03       Impact factor: 3.240

5.  Cage size, movement in and out of housing during daily care, and other environmental and population health risk factors for feline upper respiratory disease in nine North American animal shelters.

Authors:  Denae C Wagner; Philip H Kass; Kate F Hurley
Journal:  PLoS One       Date:  2018-01-02       Impact factor: 3.240

6.  Effects of certain stress factors on the re-excretion of infectious laryngotracheitis virus from latently infected carrier birds.

Authors:  C S Hughes; R M Gaskell; R C Jones; J M Bradbury; F T Jordan
Journal:  Res Vet Sci       Date:  1989-03       Impact factor: 2.534

Review 7.  Feline infectious disease control in shelters.

Authors:  Kate F Hurley
Journal:  Vet Clin North Am Small Anim Pract       Date:  2005-01       Impact factor: 2.093

8.  Felid herpesvirus type 1 infection in cats: a natural host model for alphaherpesvirus pathogenesis.

Authors:  Roger Maes
Journal:  ISRN Vet Sci       Date:  2012-11-14

Review 9.  Feline herpesvirus infection. ABCD guidelines on prevention and management.

Authors:  Etienne Thiry; Diane Addie; Sándor Belák; Corine Boucraut-Baralon; Herman Egberink; Tadeusz Frymus; Tim Gruffydd-Jones; Katrin Hartmann; Margaret J Hosie; Albert Lloret; Hans Lutz; Fulvio Marsilio; Maria Grazia Pennisi; Alan D Radford; Uwe Truyen; Marian C Horzinek
Journal:  J Feline Med Surg       Date:  2009-07       Impact factor: 2.015

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.